Genomic Analysis Identifies Risk Factors in Restless Legs Syndrome

Ann Neurol. 2024 Nov;96(5):994-1005. doi: 10.1002/ana.27040. Epub 2024 Jul 30.

Abstract

Objective: Restless legs syndrome (RLS) is a neurological condition that causes uncomfortable sensations in the legs and an irresistible urge to move them, typically during periods of rest. The genetic basis and pathophysiology of RLS are incompletely understood. We sought to identify additional novel genetic risk factors associated with RLS susceptibility.

Methods: We performed a whole-genome sequencing and genome-wide association meta-analysis of RLS cases (n = 9,851) and controls (n = 38,957) in 3 population-based biobanks (All of Us, Canadian Longitudinal Study on Aging, and CARTaGENE).

Results: Genome-wide association analysis identified 9 independent risk loci, of which 8 had been previously reported, and 1 was a novel risk locus (LMX1B, rs35196838, OR 1.14, 95% CI 1.09-1.19, p value = 2.2 × 10-9). Furthermore, a transcriptome-wide association study also identified GLO1 and a previously unreported gene, ELFN1. A genetic correlation analysis revealed significant common variant overlaps between RLS and neuroticism (rg = 0.40, se = 0.08, p value = 5.4 × 10-7), depression (rg = 0.35, se = 0.06, p value = 2.17 × 10-8), and intelligence (rg = -0.20, se = 0.06, p value = 4.0 × 10-4).

Interpretation: Our study expands the understanding of the genetic architecture of RLS, and highlights the contributions of common variants to this prevalent neurological disorder. ANN NEUROL 2024;96:994-1005.

Publication types

  • Meta-Analysis

MeSH terms

  • Genetic Predisposition to Disease / genetics
  • Genome-Wide Association Study*
  • Genomics
  • Humans
  • Polymorphism, Single Nucleotide / genetics
  • Restless Legs Syndrome* / epidemiology
  • Restless Legs Syndrome* / genetics
  • Risk Factors
  • Whole Genome Sequencing